Bernard Chevallier
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 1
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Henri Roché (3 shared papers)P. Chollet (2 shared papers)P Hurteloup (1 shared paper)Jean Pierre Olivier (1 shared paper)P Bastit (3 shared papers)Bernard Asselain (2 shared papers)Bertrand Delpech (2 shared papers)Corinne Veyret (2 shared papers)
- Journals
- Cancer (3 papers)Circulation (1 paper)Investigational New Drugs (1 paper)Journal of Clinical Oncology (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- FranceNetherlandsGermany
In The Last Decade
Bernard Chevallier
12 papers receiving 562 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 260
- Oncology 255
- Pathology and Forensic Medicine 108
- Obstetrics and Gynecology 34
- Cell Biology 63
Countries citing papers authored by Bernard Chevallier
This map shows the geographic impact of Bernard Chevallier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Chevallier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Chevallier more than expected).
Fields of papers citing papers by Bernard Chevallier
This network shows the impact of papers produced by Bernard Chevallier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Chevallier. The network helps show where Bernard Chevallier may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Chevallier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 188 | |
| 2 | 1988 | 80 | |
| 3 | 1990 | 72 | |
| 4 | 1987 | 63 | |
| 5 | 1995 | 51 | |
| 6 | 1999 | 49 | |
| 7 | 2006 | 27 | |
| 8 | 1995 | 20 | |
| 9 | 1997 | 14 | |
| 10 | 1999 | 9 | |
| 11 | 1995 | 2 | |
| 12 | 2008 | 1 | |
| 13 | Josephine: Napoleon's Incomparable Empress | 2002 | 1 |
| 14 | L'impératrice Joséphine | 1988 | 0 |
About Bernard Chevallier
Bernard Chevallier is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 14 papers that have together received 577 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Estrogen and related hormone effects (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (260 citations), Oncology (255 citations), Pathology and Forensic Medicine (108 citations), Obstetrics and Gynecology (34 citations) and Cell Biology (63 citations). Bernard Chevallier has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include Henri Roché, P. Chollet, P Hurteloup, Jean Pierre Olivier, P Bastit, Bernard Asselain, Bertrand Delpech, Corinne Veyret, A Kunlin and Y Graïc. Their work appears in journals such as Cancer, Circulation, Investigational New Drugs, Journal of Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.